Fundamentals of Multiple Sclerosis Care – Part 3: Current and Emerging Therapies and Symptom Management
Fundamentals of Multiple Sclerosis Care – Part 3: Current and Emerging Therapies and Symptom Management is organized by Consortium of Multiple Sclerosis Centers (CMSC).
Release date: February 1, 2022
Valid through: January 31, 2024
Description
Session 3 of Fundamentals of Multiple Sclerosis Care offers an insight into multidisciplinary considerations to include DMTs, practical nursing approaches to infusible therapies, role of specialty pharmacists in MS medication side effect management and a review of emerging therapies.
Learning Objectives
Upon completing this activity, participants should be better able to:
MS Management
• Examine the various models of care in MS and the roles and responsibilities of care team members in order to adapt the most appropriate model for team-based care in a given practice setting.
• Integrate the complex processes that support the provision of team-based, comprehensive care in MS into effective practices and centers providing evidence-based MS care.
• Integrate information about the mechanisms underlying MS relapses, progression, and gray and white matter pathology as the basis for monitoring and treating the disease.
• Summarize methods to monitor treatment outcomes including patient self-report, automated self-assessment, new clinician reported outcomes, imaging, and biomarkers in order to optimize their utilization in clinical practice and research.
Nursing
• Analyze and integrate the conceptual framework under which MS nurses construct individualized interventions and monitor outcomes in the care of patients with MS.
• Evaluate current nursing practice in various models of care utilized in settings in North America and internationally.
• Incorporate specific and evidence-based nursing skills into the development of team-based plans for individualized care of patients and families affected by MS.
Symptomatic Management
• Analyze common symptoms of MS and their appropriate pharmacologic and non-pharmacologic interventions in order to develop strategies designed to maximize function and quality of life.
• Identify assessment techniques to isolate those factors that affect the manifestation of the complex symptomatology of MS and differentiate between acute and chronic MS symptoms.
Additional details will be posted as soon as information is available.